Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling Brisbane, CA – CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced […]

Singapore – Singleron Biotechnologies, a global leader in single cell multi-omics solutions, today announced a strategic partnership with DKSH, a leading distributor of advanced life science products in Australia and New Zealand. With this partnership, DKSH will become the exclusive distributor of Singleron’s innovative single cell multi-omics solutions in Australia and New Zealand. DKSH will provide Singleron’s comprehensive […]

Uppsala, Sweden – Scienta Omicron AB and Scienta Omicron GMBH (hereinafter collectively referred to as “Scienta Omicron”) announce an update to their organizational structure and customer support model in Japan. As part of a strategic review of its regional operations, Scienta Omicron has decided to transition from a direct office presence in Japan to an exclusive distributor model. This change is […]

Xenocs is pleased to announce a new collaboration with FOM Technologies, a leading provider of precision coating solutions. This strategic partnership brings together two innovation-driven organizations at the forefront of material science research. Xenocs, headquartered in Grenoble, France, provides cutting-edge solutions for nanoscale characterization, empowering researchers and engineers to push the boundaries of material development. With […]

WILMINGTON, Del.–Predicting how a person’s heart will respond to a new medicine remains one of the most persistent blind spots in drug development. Even with decades of scientific progress, cardiotoxicity can still emerge unexpectedly, carrying enormous financial costs and, more importantly, real human consequences. Today, that challenge is being met with a bold new vision. […]

SALT LAKE CITY — Wasatch BioLabs (WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct Targeted Methylation Sequencing (dTMS) platform. The collaboration brings together Agilent’s enrichment chemistries—SureSelect for genomic DNA and Avida for cell-free DNA—and WBL’s proprietary Oxford Nanopore-based native-read workflow, expanding […]

Collaboration pairs robust synthetic biology platform with massive scale single cell sequencing to overcome long-standing challenges in variant mapping SEATTLE — Parse Biosciences, the leading provider of scalable and accessible single cell sequencing solutions, today announced a collaboration with Codebreaker Labs to develop and validate a breakthrough platform capable of testing thousands of genetic variants […]

CAMBRIDGE, Mass. & SAN DIEGO — Quantori, a leading provider of digital transformation services and technology for the life sciences and healthcare industries, and Expert Systems, a pioneer in next-generation AI solutions, today announced a strategic collaboration focused on developing and commercializing foundational predictive models for pharmaceutical research and development. This partnership will integrate Expert Systems’ […]

CAMBRIDGE, Mass. — TileDB has announced the launch of TileDB Carrara, the omnimodal data intelligence platform, as a Snowflake Connected App for Healthcare & Life Sciences. This integration enables organizations to unify complex scientific and multimodal data—including genomics, proteomics, medical imaging, and documents—that live in both TileDB and Snowflake, providing a unified view and streamlined […]

BD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person Immune Profiling Study FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic collaboration with the Institute for Immunology and Immune Health (I3H) […]